GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Huons Global Co 084110.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

18,880

+0.43%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩847.45bn

FY2016FY2025

Net income

₩28.84bn

FY2016FY2025

Free cash flow

₩41.73bn

FY2016FY2025

Shareholders' equity

₩546.71bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩847.45bn₩813.46bn₩758.38bn₩664.36bn₩574.65bn₩523.05bn₩449.42bn₩378.69bn₩323.96bn₩163.71bn
Gross profit₩410.89bn₩420.41bn₩418.21bn₩365.63bn₩323.38bn₩291.08bn₩256.19bn₩223.76bn₩195.62bn₩88.65bn
Research and development₩66.88bn₩65.76bn₩59.59bn₩52.54bn₩45.81bn₩38.43bn₩34.46bn₩28.60bn₩26.90bn₩13.47bn
Operating income₩90.75bn₩86.08bn₩118.33bn₩4.27bn₩68.45bn₩88.73bn₩70.82bn₩72.92bn₩62.21bn₩24.95bn
Net income₩28.84bn₩25.79bn₩38.38bn−₩60.25bn₩3.99bn₩42.70bn₩26.66bn₩29.45bn₩25.65bn₩514.64bn
Diluted earnings per share2,362.582,117.493,133.85-4,919.48306.423,420.082,455.692,343.222,363.2140,943.47

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩1.56trn₩1.41trn₩1.32trn₩1.24trn₩1.28trn₩949.02bn₩742.15bn₩672.88bn₩610.15bn₩557.06bn
Cash and short-term investments—₩277.28bn₩312.55bn₩367.86bn₩373.15bn₩225.42bn₩92.21bn₩86.51bn₩95.70bn₩97.82bn
Total liabilities₩468.69bn₩885.84bn₩407.29bn₩778.79bn₩745.91bn₩536.19bn₩363.63bn₩310.66bn₩269.00bn₩237.26bn
Debt₩100.17bn₩304.24bn₩254.93bn₩289.55bn₩250.45bn₩192.30bn₩77.78bn₩65.29bn₩60.67bn₩55.53bn
Shareholders' equity₩546.71bn₩520.11bn₩501.83bn₩464.32bn₩537.84bn₩412.83bn₩378.53bn₩362.21bn₩341.14bn₩319.80bn
Shares outstanding12m12m12m12m13m12m11m13m11m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩93.61bn₩100.57bn₩99.97bn₩63.04bn₩49.82bn₩90.59bn₩65.55bn₩53.42bn₩47.52bn₩19.38bn
Capital spending−₩51.87bn−₩133.77bn−₩79.77bn−₩75.91bn−₩144.45bn−₩64.13bn−₩35.33bn−₩52.64bn−₩45.23bn−₩30.57bn
Free cash flow₩41.73bn−₩33.19bn₩20.19bn−₩12.87bn−₩94.63bn₩26.47bn₩30.22bn₩778.0m₩2.29bn−₩11.18bn
Dividends paid−₩25.61bn−₩15.60bn−₩19.48bn−₩11.84bn−₩10.12bn−₩11.24bn−₩12.10bn−₩10.11bn−₩6.38bn−₩7.74bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩214.14bn₩196.95bn₩224.52bn₩211.17bn₩212.66bn₩199.10bn₩202.51bn₩199.42bn
Gross profit₩96.70bn₩94.78bn₩99.62bn₩99.21bn₩106.66bn₩105.01bn₩101.96bn₩94.86bn
Operating income₩19.47bn₩9.16bn₩19.58bn₩20.34bn₩25.27bn₩31.48bn₩19.08bn₩14.37bn
Net income−₩776.9m₩6.09bn₩6.48bn₩10.78bn₩395.9m₩11.18bn₩2.03bn₩2.63bn
Diluted earnings per share-63.65499.27530.79885.0932.51918.13166.59215.56
Cash from operations₩22.29bn₩30.10bn₩30.71bn₩22.89bn₩13.39bn₩26.62bn₩100.57bn₩74.26bn
Capital spending−₩14.28bn−₩9.89bn−₩15.47bn−₩19.80bn−₩9.84bn−₩6.34bn−₩133.77bn−₩109.97bn
Free cash flow₩8.01bn₩20.20bn₩15.24bn₩3.09bn₩3.54bn₩20.28bn−₩33.20bn−₩35.72bn
Total assets₩1.54trn₩1.56trn₩1.56trn₩1.47trn₩1.45trn₩1.42trn₩1.41trn₩1.37trn
Cash and short-term investments——————₩277.28bn₩267.79bn
Debt₩68.26bn₩83.77bn₩100.17bn₩80.09bn₩68.45bn₩83.96bn₩248.31bn₩231.48bn
Shareholders' equity₩554.06bn₩550.50bn₩546.71bn₩536.59bn₩530.62bn₩526.78bn₩520.11bn₩516.69bn

Financial ratios

Data as of 31 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017
Gross margin48.5%51.7%55.1%55.0%56.3%55.7%——
Operating margin10.7%10.6%15.6%0.6%11.9%17.0%——
Net margin3.4%3.2%5.1%-9.1%0.7%8.2%——
Return on equity5.3%5.0%7.6%-13.0%0.7%10.3%——
Return on assets1.8%1.8%2.9%-4.8%0.3%4.5%——
Free cash flow yield——————35.7%32.8%
Revenue growth4.2%7.3%14.2%15.6%9.9%16.4%——
Earnings growth11.8%-32.8%-163.7%-1608.4%-90.6%60.2%——
Current ratio1.92x1.89x1.96x1.66x1.81x1.80x——
Debt to equity0.18x0.47x0.38x0.38x0.38x0.42x——
Equity ratio35.0%37.0%38.1%37.4%41.9%43.5%——
Interest coverage7.25x8.22x9.87x0.33x9.60x30.49x——
R&D as a share of sales7.9%8.1%7.9%7.9%8.0%7.3%——
Buybacks as a share of market value——————-0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.5%10.1%29.2%
Operating income177.1%0.5%22.4%
Net income—-7.5%-1.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.1%52.4%53.3%54.3%
Operating margin10.6%9.7%10.9%12.6%
Net margin3.3%1.1%1.9%12.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings21.720.47.5-3.8125.68.213.016.319.40.7
Price to sales0.70.70.40.30.90.70.81.31.52.1

Dividends and splits

Per share, in the currency the company pays

Paid for 20 years. Last went ex-dividend on 28 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year800.00930.00550.00250.00500.00500.00362.811345.535
  • 21-for-20 split · 29 Dec 2021
  • 21-for-20 split · 29 Dec 2020
  • 21-for-20 split · 27 Dec 2019
  • 21-for-20 split · 27 Dec 2018
  • 21-for-20 split · 27 Dec 2017
  • 1.02-for-1 split · 28 Dec 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.